LOS ANGELES, July 9, 2019 /PRNewswire/ -- Zynx Health™, market leader in providing evidence- and experience-based clinical improvement solutions since 1996, announced today that long-time client A

REDWOOD CITY, Calif., July 9, 2019 /PRNewswire/ -- REVOLUTION Medicines, Inc., a clinical-stage leader in the discovery and development of novel small molecule inhibitors of frontier oncology targets within notorious pathways, today announced the closing of a $100 million Series C equity financing.  Proceeds will support continued

TORONTO and HOUSTON, July 9, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received US$1,915,264 (approximately, CD$2.5M) from the Cancer Prevention and Research Institute of

NEW ORLEANS, July 9, 2019 /PRNewswire/ -- AxoSim, Inc., the premier provider of neuroscience discovery platforms that mimic the structure and function of the human nervous system, today announced publication of a new 

Now Available at Major U.S. Retailers BRIDGEWATER, N.J., July 9, 2019 /PRNewswire/ -- Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TXS: BHC), today announced the U.S. launch of Ocuvite® Eye Performance vitamins, a nutritional supplement designed to meet the changing need

CAMBRIDGE, Mass., July 9, 2019 /PRNewswire/ -- EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for the cognitive dysfunction associated with Huntington's disease, a rare, genetically inherited disease that causes the ne

SAN RAMON, Calif., July 9, 2019 /PRNewswire/ -- Board-Certified urologist and specialist in male sexual medicine, Dr. Judson Brandeis, is launching the world's lar

DALLAS and NASHVILLE, Tenn., July 9, 2019 /PRNewswire/ -- Pharos Capital Group, LLC, a physician-founded healthcare private equity firm based in Dallas and Nashville, today announced that it has promoted Ryan Shelton to Principal, effecti

ISFIYA, Israel, July 9, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only preparation-free capsule based

PORTLAND, Maine, July 9, 2019 /PRNewswire/ -- MedRhythms, a Portland, Maine-based digital therapeutics company, today announced the addition of a Stroke Scientific Advisory Board. The company is developing digital therapeutics, which use sensors, software, and music to support gait rehabilitation in adults suffering from neurologic injuri